“Debilitating a Generation”: Expert Warns That Long COVID May Eventually Affect Most AmericansCOVID#LongCOVID#COVID#Disability#International#AirborneTransmission#Accommadation#BrainDamage#Children#Cardiovascular#ChronicallyIll#Death#COVIDVariant#Disinformation#DisabledPeople#Immunocompromised#JAMA#Pandemic#PublicHealth#SolutionsNeeded#SocialNorms#Vaccination·ineteconomics.org·Jun 17, 2024“Debilitating a Generation”: Expert Warns That Long COVID May Eventually Affect Most Americans
Doctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ StrainsCOVID#COVID#COVIDVariant#Denialism·prevention.com·May 10, 2024Doctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ Strains
This website is unavailable in your location. – KIRO 7 News SeattleCOVID#COVID#COVIDVariant#Denialism·kiro7.com·May 10, 2024This website is unavailable in your location. – KIRO 7 News Seattle
What to Know about the New COVID Variant JN.1COVID#COVIDVariant#COVID#JN.1#Masking#Vaccination·scientificamerican.com·Jan 9, 2024What to Know about the New COVID Variant JN.1
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressureCOVID#COVID#COVIDVariant#JN.1·biorxiv.org·Jan 9, 2024Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
Fact check: Researchers found coronavirus in March 2019 wastewater; more study neededCOVID#COVID#OriginsofCOVID#COVIDVariant#Factcheck·usatoday.com·Dec 21, 2023Fact check: Researchers found coronavirus in March 2019 wastewater; more study needed
New UW study examines COVID-19 vaccines in people with weakened immune systemsCOVID#Novavax#COVID#COVIDVariant#Effectiveness#Health#Immunocompromised·med.wisc.edu·Nov 19, 2023New UW study examines COVID-19 vaccines in people with weakened immune systems
What to Know About the Updated COVID-19 Vaccine for Fall/Winter 2023 | Johns Hopkins Bloomberg School of Public HealthCOVID#COVID#PublicHealth#COVIDVariant#Vaccination#Novavax·publichealth.jhu.edu·Sep 26, 2023What to Know About the Updated COVID-19 Vaccine for Fall/Winter 2023 | Johns Hopkins Bloomberg School of Public Health
Recombinant Nanoparticle Vaccine Technology | NovavaxCOVID#COVIDVariant#PublicHealth#Vaccination#COVID#Novavax·novavax.com·Sep 26, 2023Recombinant Nanoparticle Vaccine Technology | Novavax
What You Need to Know About the Novavax Protein-Based Vaccine | Johns Hopkins Bloomberg School of Public HealthCOVID#COVID#PublicHealth#COVIDVariant#Vaccination#Novavax·publichealth.jhu.edu·Sep 26, 2023What You Need to Know About the Novavax Protein-Based Vaccine | Johns Hopkins Bloomberg School of Public Health
COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands onCOVID#COVID#COVIDVariant#Pirola#PublicHealth#Vaccination·fortune.com·Sep 17, 2023COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands on
DOH awards $415K contract for new COVID surveillance call centerCOVID#COVID#COVIDVariant#Hawai'i#CallCenter·khon2.com·Sep 13, 2023DOH awards $415K contract for new COVID surveillance call center
Covid-19: Scientists sound alarm over new BA.2.86 “Pirola” variantCOVID#COVID#COVIDVariant#USA#Pirola#Eris·bmj.com·Aug 30, 2023Covid-19: Scientists sound alarm over new BA.2.86 “Pirola” variant
COVID-19 Variant Dashboard - USACOVID#Dashboard#COVIDVariant#COVID#USA#Hawai'i·public.tableau.com·Aug 30, 2023COVID-19 Variant Dashboard - USA
Highly mutated COVID variant BA.2.86 has been detected in the U.S. Why the CDC and WHO are monitoring itCOVID#COVID#COVIDVariant#Pirola#Eris#Fornax·fortune.com·Aug 30, 2023Highly mutated COVID variant BA.2.86 has been detected in the U.S. Why the CDC and WHO are monitoring it
State warns of COVID uptick on Maui, statewideCOVID#Maui#COVID#Wildfire#N95#Masking#Hawai'i#Pirola#COVIDVariant·staradvertiser.com·Aug 30, 2023State warns of COVID uptick on Maui, statewide
New COVID-19 Variants Giving ‘Arcturus’ a Run for its MoneyCOVID#COVID#COVIDVariant#Arcturus·usnews.com·Aug 29, 2023New COVID-19 Variants Giving ‘Arcturus’ a Run for its Money